These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2419543)
1. Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas. Lin CW; Bianchi BR; Grant D; Miller T; Danaher EA; Tufano MD; Kopecka H; Nadzan AM J Pharmacol Exp Ther; 1986 Mar; 236(3):729-34. PubMed ID: 2419543 [TBL] [Abstract][Full Text] [Related]
2. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species. Bianchi BR; Miller TR; Witte DG; Lin CW J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394 [TBL] [Abstract][Full Text] [Related]
3. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685 [TBL] [Abstract][Full Text] [Related]
4. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors. Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous measurement of cholecystokinin-stimulated amylase release and cholecystokinin receptor binding in rat pancreatic acini. Blevins GT; Doi R; Tangoku A; Chowdhury P; McKay D; Rayford PL J Lab Clin Med; 1992 May; 119(5):566-73. PubMed ID: 1374786 [TBL] [Abstract][Full Text] [Related]
6. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. Gardner JD; Knight M; Sutliff VE; Jensen RT Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257 [TBL] [Abstract][Full Text] [Related]
7. Role of calcium in cholecystokinin-stimulated phosphoinositide breakdown in exocrine pancreas. Pandol SJ; Thomas MW; Schoeffield MS; Sachs G; Muallem S Am J Physiol; 1985 May; 248(5 Pt 1):G551-60. PubMed ID: 2581457 [TBL] [Abstract][Full Text] [Related]
8. 125I-(Thr34, Nle37)- CCK31-39 a non oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides. Fourmy D; Pradayrol L; Vaysse N; Susini C; Ribet A J Immunoassay; 1984; 5(1-2):99-120. PubMed ID: 6201510 [TBL] [Abstract][Full Text] [Related]
10. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini. Iwamoto Y; Yamamoto R; Kuzuya T Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574 [TBL] [Abstract][Full Text] [Related]
11. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors. Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251 [TBL] [Abstract][Full Text] [Related]
12. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984 [TBL] [Abstract][Full Text] [Related]
13. Discovery of a cholecystokinin analogue with partial agonist activity. Howard JM; Knight M; Jensen RT; Gardner JD Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732 [TBL] [Abstract][Full Text] [Related]
14. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats. Chowdhury P; Rayford PL Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849 [TBL] [Abstract][Full Text] [Related]
15. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini. Sarri E; Ramos B; Salido GM; Claro E Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507 [TBL] [Abstract][Full Text] [Related]
16. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors. Zhou W; Povoski SP; Bell RH J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864 [TBL] [Abstract][Full Text] [Related]
17. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238 [TBL] [Abstract][Full Text] [Related]
18. Effect of cholecystokinin variant (CCK39) on dispersed acinar cells from guinea pig pancreas. Sjodin L; Gardner JD Gastroenterology; 1977 Nov; 73(5):1015-8. PubMed ID: 198332 [TBL] [Abstract][Full Text] [Related]
19. Structural requirements for action of cholecystokinin on enzyme secretion from pancreatic acini. Villanueva ML; Collins SM; Jensen RT; Gardner JD Am J Physiol; 1982 Apr; 242(4):G416-22. PubMed ID: 6175230 [TBL] [Abstract][Full Text] [Related]